Una candidatura completa in un minuto
Curriculum e lettera di presentazione personalizzati, pronti da inviare.
Evergen is seeking an Operations Analyst 2 in Alachua, FL to support supply chain analytics, inventory forecasting, and production planning. The role involves building BI reports, performing cost analyses, and coordinating the monthly SIOP process to ensure on-time delivery.
Qualifications include a BS in a relevant field and 4–6 years of manufacturing or supply-chain experience. The position offers PTO, 401(k) with company match, and comprehensive health benefits.
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
Alachua, FL, US
4 days ago Requisition ID: 2587
Salary Range: $65,000.00 To $75,000.00 Annually
Location: Alachua, FL
Annual Bonus Opportunity up to $8,000
Evergen is a global industry-leading contract development and manufacturing organization (CDMO) in regenerative medicine. As the only regenerative medicine company that offers a differentiated portfolio of allograft and xenograft biomaterials at scale, Evergen is headquartered in Alachua, FL, and has manufacturing facilities in West Lafayette, IN; Eden Prairie and Glencoe, MN; Neunkirchen, Germany; Glasgow, UK; and Marton, New Zealand.
We are proud to be Great Place to Work® Certified in 2026, reflecting our commitment to creating an exceptional employee experience and workplace culture. Evergen currently has full-time career opportunities available across multiple locations.
Evergen provides customers across a diverse set of market segments with leading‑edge expertise, scale, and flexibility across end‑to‑end services including design, development, regulatory support, verification and validation, manufacturing, and supply chain management.
Evergen is rooted in a steadfast commitment to quality, integrity, and patient safety with a focus on five key values:
At Evergen, we are committed to fostering an inclusive workplace where we embrace the richness of our diversity and ensure that every voice is heard, respected, and celebrated. We believe that by embracing diversity and promoting inclusivity, we not only uphold our values but also strengthen our position as the CDMO of Choice in regenerative medicine solutions. We recognize that cultivating a growth mindset is essential to our success, and we are dedicated to continuous learning and improvement in our diversity, equity, and inclusion efforts. Through accountability and action, we strive to create an environment where individuals can thrive, innovate, and contribute their unique perspectives to drive our collective success.
Montagu Private Equity (“Montagu”), a leading European private equity firm, acquired RTI in 2020 and has supported the transformation of the company to its next level of potential.